Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Parkinson's Disease Research, Education, and Clinical Center, Philadelphia
With
Children's Hospital of Philadelphia
Current research seeks to provide a drug-free, non-invasive and non-toxic therapy for Parkinson's disease through transcranial magnetic stimulation (TMS) in the form of picoTesla magnetic therapy (pTMT). This therapy consists of an electronic device that emits magnetic flux densities that are more than ten million times lower than the magnetic flux density of the earth's magnetic field. Repetitive transcranial magnetic stimulation (rTMS) therapy aims to manipulate overall quality of life by improving motor function, as well as cognitive and neuropsychiatric symptoms such as depression.
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
40 to 80 years of age
Diagnosis of possible or probable PD by the UK Brain Bank clinical diagnostic criteria
Stable anti-Parkinsonian medical regimen for at least 30 days prior to enrollment
Hoehn \& Yahr Scale score of I to III
No evidence of secondary or atypical Parkinsonism on MRI test in the past year
Subjects are capable of giving informed consent
You may not be if
Contraindications to MRI (e.g. cardiac pacemaker, claustrophobia, metal fragments or hardware within the orbit or cranium)
History of stroke or TIA within the past year
Dementia defined as a MMSE score \< 25
Status post deep brain stimulation surgery
Unstable medical conditions that would likely prevent the subject from completing the study